We've just published a brand-new report on our favorite 3 stocks that we believe you can buy and hold "forever."

Our 3 Top 'Buy and Hold Forever' Stocks Right Now We've just published a brand-new report on our favorite 3 stocks that we believe you can buy and hold "forever." If you've followed our research in recent years, you know there's a small group of stocks (40 in all) that meet our incredibly strict criteria to qualify as forever stocks. Since we first published a portfolio of 14 forever stocks in March of 2020, these investments have done incredibly well... Not one single loser, and an AVERAGE return of more than 150%! If you want to learn more about these powerful businesses and how to use them to create a permanent portfolio, Doc Eifrig and our founder, Porter Stansberry, recently sat down to explain everything you need to know. In this talk, they also go over stock market ticker symbols and exact allocation percentages. This strategy could be the perfect approach for you right now – a way to stay in stocks, and NOT have to worry if there's a dramatic market fall. To see Doc's and Porter's discussion, click here before it's pulled offline tomorrow. Sincerely, Brett Aitken Publisher, Stansberry Research Published by Stansberry Research. You have received this e-mail as part of your optin to Stansberry Research. If you no longer wish to receive special offers from Stansberry Research, click here. You're receiving this e-mail at edwardlorilla1986.paxforex@blogger.com. Stansberry Research welcomes comments or suggestions at feedback@stansberryresearch.com . This address is for feedback only. For questions about your account or to speak with customer service, call 888-261-2693 (U.S.) or 443-839-0986 (international) Monday-Friday, 9 a.m.-5 p.m. Eastern time. Or e-mail info@stansberryresearch.com. Please note: The law prohibits us from giving personalized financial advice. © 2024 Stansberry Research. All rights reserved. Any reproduction, copying, or redistribution, in whole or in part, is prohibited without written permission from Stansberry Research, 1125 N Charles St, Baltimore, MD 21201 stansberryresearch.com.